Coprimary efficacy endpoints were the proportions of treatment responders , defined as a 1-point reduction in SMF on the Clinician-Reported Submental Fat Rating Scale ( CR-SMFRS ) , and those satisfied with their appearance in association with their face and chin after treatment on the Subject Self-Rating Scale ( SSRS score 4 ) .